Onkos Surgical received FDA 510(k) clearance to market the ELEOS™ Limb Salvage System to treat bone loss due to cancer, trauma or previous surgical procedures. Full launch is slated for 1Q17.
Other companies with limb salvage systems include Stanmore Implants (acquired by Stryker), Wright Medical and Zimmer Biomet.
Sources: Onkos Surgical; ORTHOWORLD Inc.
Onkos Surgical received FDA 510(k) clearance to market the ELEOS™ Limb Salvage System to treat bone loss due to cancer, trauma or previous surgical procedures. Full launch is slated for 1Q17.
Other companies with limb salvage systems include Stanmore Implants (acquired by...
Onkos Surgical received FDA 510(k) clearance to market the ELEOS™ Limb Salvage System to treat bone loss due to cancer, trauma or previous surgical procedures. Full launch is slated for 1Q17.
Other companies with limb salvage systems include Stanmore Implants (acquired by Stryker), Wright Medical and Zimmer Biomet.
Sources: Onkos Surgical; ORTHOWORLD Inc.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.





